Cargando…
Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers
INTRODUCTION: Transthyretin amyloidosis (ATTR amyloidosis), whether manifesting as familial amyloid polyneuropathy (ATTR-PN) or cardiomyopathy (ATTR-CM), is a progressive, debilitating, and often fatal, rare disease requiring significant caregiver support. This study aims to better characterize the...
Autores principales: | Stewart, Michelle, Shaffer, Shannon, Murphy, Brian, Loftus, Jane, Alvir, Jose, Cicchetti, Michael, Lenderking, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283802/ https://www.ncbi.nlm.nih.gov/pubmed/30073497 http://dx.doi.org/10.1007/s40120-018-0106-z |
Ejemplares similares
-
Latent Class Analysis to Classify Patients with Transthyretin Amyloidosis by Signs and Symptoms
por: Alvir, Jose, et al.
Publicado: (2015) -
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
por: Li, Benjamin, et al.
Publicado: (2020) -
Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Mundayat, Rajiv, et al.
Publicado: (2018) -
Burden of hereditary transthyretin amyloidosis on quality of life
por: Yarlas, Aaron, et al.
Publicado: (2019) -
A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosis
por: Acaster, Sarah, et al.
Publicado: (2023)